Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Elekta    EKTA B   SE0000163628

ELEKTA (EKTA B)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 12/14 05:29:38 pm
113.35 SEK   -1.22%
11/26ELEKTA AB (PUBL) : half-yearly earnings release
08/27ELEKTA AB (PUBL) : quaterly earnings release
05/29ELEKTA AB (PUBL) : annual earnings release
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Elekta : wins user-centered product design award for its MR-linac, Elekta Unity

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/03/2018 | 02:31pm CET

Award affirms Elekta's and DCA's ability to innovate new technology while remaining focused on physician and patient needs

PHILADELPHIA, USA, October 3, 2018 - Elekta (EKTA-B.ST) and DCA Design International Ltd have won the prestigious Human Factors and Ergonomics Society (HFES) Stanley H. Caplan User-Centered Product Design Award 2018 for Elekta Unity, Elekta's MR-linac. Elekta Unity combines high-field 1.5 Tesla MR imaging, precision radiation therapy and intelligent software, giving clinicians the previously unattainable ability to see what they treat in real time. This U.S.-based award recognizes outstanding and innovative practice in product design, alongside the user research and design methods used to both develop and evaluate the design from the early product vision to the commercially available system, which received CE-mark in June 2018.

"The needs of the patients and healthcare professionals were considered from the very outset of the project," said David Gilmore, Director of User Experience at Elekta. "The vision for Unity was informed by a global research exercise that involved observing over 360 clinical treatment sessions, across seven treatment centers, along with more than 50 in-depth interviews. A wide range of tools from the fields of human factors and design research were used to analyze this data, directly inspiring and informing the product design."

Dr. Gilmore and Daniel Jenkins, DCA's Human Factors and Usability Senior Skill Leader, received the award on behalf of Elekta and DCA on October 2 at the HFES Annual Meeting in Philadelphia where they also delivered a joint presentation on the product and design methodologies employed.

Rob Woolston, Managing Director at DCA added: "We are extremely proud to receive this award alongside Elekta and for the recognition of the key role that user centered design has played in the development of Unity. This award, combined with the iF Award received earlier this year for the class-leading visual design of Unity, help to illustrate and celebrate the breadth and depth of skills involved in progressing Unity from brief to reality through a fully-integrated, evidence-based design approach. We are delighted to have been so deeply involved with this project, especially given the tremendous impact that Unity will have on the lives of cancer patients."

To learn more, visit elekta.com/Unity (http://www.elekta.com/Unity).

Elekta Unity is pending 510(k) pre-market clearance and not available for commercial distribution or sale in the U.S. 

# # #

For further information, please contact:
Oskar Bosson, Global EVP Corporate Communications and Investor Relations
Tel: +46 70 410 7180, e-mail: Oskar.Bosson@elekta.com
Time zone: CET: Central European Time 

Raven Canzeri, Global Public Relations Manager
Tel: +1 770 670 2524, e-mail: raven.canzeri@elekta.com
Time zone: EST: Eastern Standard Time

About Elekta
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,700 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com 

http://news.cision.com/elekta/r/elekta-wins-user-centered-product-design-award-for-its-mr-linac--elekta-unity,c2634188

http://mb.cision.com/Main/35/2634188/920410.pdf

http://news.cision.com/elekta/i/mr-linac-with-technology-cutout,c2501742

(c) 2018 Cision. All rights reserved., source Press Releases - English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ELEKTA
12/05EUROPE : Growth and trade nerves grind European shares down to two-week low
RE
12/05ELEKTA : Unity, world's first high field MR-linac, receives FDA 510(k) clearance
AQ
11/29ELEKTA : Interim report May-October 2018/19 Q2
AQ
11/26ELEKTA AB (PUBL) : half-yearly earnings release
11/16ELEKTA : Conference call regarding Elekta's Q2 report for 2018/19
AQ
11/15ELEKTA : Nomination Committee for the 2019 Annual General Meeting
AQ
11/14ELEKTA : GenesisCare signs MoU for Versa HD cancer treatment systems and researc..
AQ
11/01ELEKTA : Unity MR-linac featured in 11 abstracts at ASTRO 2018
AQ
10/19ELEKTA : Allegheny Health Network Cancer Institute invests in Elekta's MR-linac ..
PU
10/19ELEKTA : Allegheny Health Network Cancer Institute invests in Elekta's MR-linac ..
AQ
More news
Financials (SEK)
Sales 2019 13 122 M
EBIT 2019 1 864 M
Net income 2019 1 374 M
Finance 2019 495 M
Yield 2019 1,32%
P/E ratio 2019 31,71
P/E ratio 2020 26,32
EV / Sales 2019 3,15x
EV / Sales 2020 2,77x
Capitalization 41 779 M
Chart ELEKTA
Duration : Period :
Elekta Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELEKTA
Short TermMid-TermLong Term
TrendsBullishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 117  SEK
Spread / Average Target 3,4%
EPS Revisions
Managers
NameTitle
Richard Hausmann President & Chief Executive Officer
Laurent Leksell Chairman
Steven Mark Wort Chief Operating Officer
Gustaf Salford Chief Financial Officer & Executive Vice President
John Lapré Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
ELEKTA67.31%4 612
THERMO FISHER SCIENTIFIC23.34%94 279
DANAHER CORPORATION8.17%70 371
INTUITIVE SURGICAL34.76%56 165
BOSTON SCIENTIFIC CORPORATION49.17%49 540
ILLUMINA49.42%47 990